New research has shown the Gardasil vaccination of teenage girls has led to a decrease in the HPV virus that causes cervical cancer. The program is being expanded and another stronger vaccine is on the way, in the wake of the program’s success. Researchers at The Royal Women’s Hospital found a 77 per cent decrease in some human papilloma virus types as a result of the Gardasil program. It’s been only five years since teenage girls began receiving the vaccination. From next year, teenage boys will also be part of the vaccination program.
HPV currently affects an estimated 75% to 80% of both males and females in their lifetime.Biomedical company Allied Healthcare Group is now working with Gardasil creator Professor Ian Frazer to develop further treatment.